Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: Low concentration flufenamic acid enhances osteogenic differentiation of mesenchymal stem cells and suppresses bone loss by inhibition of the NF-κB signaling pathway

Fig. 1

FFA at different concentrations affected osteogenic differentiation of hBMMSCs in vitro. a 25, 50, and 100 μM FFA increased ALP activity in hBMMSCs, whereas 200 μM FFA decreased ALP activity as shown by ALP staining. Human BMMSCs were cultured in PM, OM, or OM with FFA at 25, 50,100, or 200 μM for 7 days. b FFA at 25, 50, and 100 μM accelerated mineralization in hBMMSCs, whereas 200 μM FFA reduced mineralization as shown by ARS staining. Human BMMSCs were cultured in PM, OM, or OM with FFA at 25, 50,100, or 200 μM for 14 days. c The result of quantification of ALP activity was consistent with the result of ALP staining. d The result of quantification of ARS was consistent with the result of ARS staining. e FFA at 25, 50, and 100 μM promoted the expression of ALP and RUNX2 on day 7. However, 200 μM FFA inhibited the expression of the genes mentioned above, as determined by qRT-PCR. f FFA at 25, 50, and 100 μM promoted the expression of RUNX2 and BGLAP on day 14, whereas 200 μM FFA inhibited the expression of the genes mentioned above, as determined by qRT-PCR in hBMMSCs. All data are shown as the mean ± SD, n = 3. *p < 0.05 and **p < 0.01 compared with OM. FFA, flufenamic acid; hBMMSC, human bone marrow-derived mesenchymal stem cell; PM, proliferation media; OM, osteogenic media; ALP, alkaline phosphatase; ARS, alizarin red S; RUNX2, runt-related transcription factor 2; BGLAP, bone gamma-carboxyglutamate protein; qRT-PCR, quantitative real-time reverse transcription PCR

Back to article page